Ru360 protects against vitrification-induced oocyte meiotic defects by restoring mitochondrial function

Theriogenology. 2023 Jul 1:204:40-49. doi: 10.1016/j.theriogenology.2023.04.004. Epub 2023 Apr 7.

Abstract

Oocyte vitrification has been widely application in female fertility preservation. Recent studies found that vitrification of immature (germinal vesicle stage, GV) oocytes increased the risk of aneuploidy during meiotic maturation; however, the underlying mechanisms and the strategies to prevent this defect remain unexplored. In this study, we found that vitrification of GV oocytes decreased the first polarbody extrusion rate (90.51 ± 1.04% vs. 63.89 ± 1.39%, p < 0.05) and increased the aneuploid rate (2.50% vs. 20.00%, p < 0.05), accompanied with a series of defects during meiotic maturation, including aberrant spindle morphology, chromosome misalignment, incorrect Kinetochore-Microtubule attachments (KT-MTs) and weakened spindle assembly checkpoint protein complex (SAC) function. We also found that vitrification disrupted mitochondrial function by increasing mitochondrial Ca2+ levels. Importantly, inhibition of mitochondrial Ca2+ entry by 1 μM Ru360 significantly restored mitochondrial function and rescued the meiotic defects, indicating that the increase of mitochondrial Ca2+, at least, was a cause of meiotic defects in vitrified oocytes. These results shed light on the molecular mechanisms of oocyte vitrification-induced adverse effects of meiotic maturation and provided a potential strategy to improve oocyte cryopreservation protocols further.

Keywords: Aneuploidy; KT-MTs; Mitochondrial Ca(2+); Oocyte vitrification; Ru360; SAC.

MeSH terms

  • Aneuploidy
  • Animals
  • Cryopreservation / methods
  • Cryopreservation / veterinary
  • Female
  • Fertility Preservation* / veterinary
  • Mitochondria
  • Oocytes / physiology
  • Vitrification*